Atlas Trials

A Study to Evaluate the Pharmacokinetics and Bioequivalence of Sumatriptan Delivered Via the Intraject System

Clinical trial NCT00614029 · COMPLETED

Trial details

NCT number
NCT00614029
Sponsor
Zogenix, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
PharmacokineticsBioequivalence
Start date
2006-12-01
Primary completion
2006-12-01
Enrollment
54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.